Three independent discounted-cash-flow-style models value Eli Lilly and Company every trading day. 0 of 3 currently price LLY above its market price.
| Free Cash Flow model | $214.78 |
| Excess Profit model | $863.75 |
| Residual Earnings model | $413.39 |
| Dividend Discount model | $236.96 |
| Piotroski F-Score | 7 / 9 |
| Return on invested capital | +34.0% |
| Net debt / EBITDA | 1.1× |
| Gross margin | +83.0% |
| Revenue CAGR | +31.7% |
| Cash conversion | 0.8× |
| Dividend yield | +0.6% |
| Buyback yield | +0.3% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open LLY in StockKitty